Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001Paul D. Brown, Deepak Khuntia, David R. Grosshans et al.|Journal of Clinical Oncology|2020Cited by 827
Concurrent Chemotherapy and Intensity-Modulated Radiation Therapy for Anal Canal Cancer Patients: A Multicenter ExperienceJoseph K. Salama, Steven J. Chmura, Loren K. Mell et al.|Journal of Clinical Oncology|2007Cited by 268
Association Between Bone Marrow Dosimetric Parameters and Acute Hematologic Toxicity in Anal Cancer Patients Treated With Concurrent Chemotherapy and Intensity-Modulated RadiotherapyLoren K. Mell, Steven J. Chmura, David A. Schomas et al.|International Journal of Radiation Oncology*Biology*Physics|2007Cited by 231
American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation OncologyCharles S. Mayo, Kenneth Ulin, Jean M. Moran et al.|International Journal of Radiation Oncology*Biology*Physics|2017Cited by 201
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancerDavid B. Page, Sylvia Adams, Harry D. Bear et al.|npj Breast Cancer|2019Cited by 86